Swedish Orphan Biovitrum AB (publ)
OTC:SWOBY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Swedish Orphan Biovitrum AB (publ)
OTC:SWOBY
|
SE |
|
C
|
China Minsheng Banking Corp Ltd
XBER:GHFH
|
CN |
|
China National Chemical Engineering Co Ltd
SSE:601117
|
CN |
|
Community Healthcare Trust Inc
NYSE:CHCT
|
US |
|
Soiken Holdings Inc
TSE:2385
|
JP |
|
M
|
Meta Platforms Inc
F:FB2A
|
US |
|
Japan Tobacco Inc
F:JAT
|
JP |
|
Seven & i Holdings Co Ltd
F:S6MA
|
JP |
|
F
|
Fairfax Financial Holdings Ltd
XMUN:FFX
|
CA |
|
Digital Turbine Inc
NASDAQ:APPS
|
US |
|
R
|
Reliance Home Finance Ltd
BSE:540709
|
IN |
|
Nordson Corp
NASDAQ:NDSN
|
US |
|
Rukun Raharja Tbk PT
IDX:RAJA
|
ID |
|
Samsung C&T Corp
KRX:028260
|
KR |
|
U
|
Under Armour Inc
F:U9RA
|
US |
|
Alexandria Real Estate Equities Inc
NYSE:ARE
|
US |
|
Carriage Services Inc
NYSE:CSV
|
US |
|
K
|
Kohls Corp
SWB:KHP
|
US |
|
Antipa Minerals Ltd
OTC:ATPMF
|
AU |
Bankruptcy Probability
Swedish Orphan Biovitrum AB (publ)'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Swedish Orphan Biovitrum AB (publ) Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
150.4B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
177.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
158.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
108.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Swedish Orphan Biovitrum AB (publ)'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Swedish Orphan Biovitrum AB (publ) has total debt of 7.9B SEK. This includes both short-term (0 SEK) and long-term (7.9B SEK) debt.
You can find a full breakdown on its Balance Sheet.
